Royal Fund Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Buy
2,573
+697
+37% +$91.8K 0.03% 244
2026
Q1
$261K Sell
1,876
-7,305
-80% -$1.02M 0.02% 257
2025
Q4
$1.13M Buy
9,181
+2,478
+37% +$301K 0.1% 171
2025
Q3
$744K Sell
6,703
-324
-5% -$36.8K 0.09% 172
2025
Q2
$779K Buy
7,027
+4,015
+133% +$427K 0.08% 208
2025
Q1
$338K Buy
+3,012
New +$311K 0.04% 251
2024
Q4
Sell
-22,140
Closed -$1.86M 311
2024
Q3
$1.86M Buy
22,140
+2,577
+13% +$197K 0.11% 167
2024
Q2
$1.34M Sell
19,563
-2,877
-13% -$192K 0.11% 164
2024
Q1
$1.64M Buy
22,440
+7,624
+51% +$586K 0.16% 159
2023
Q4
$1.2M Buy
+14,816
New +$1.15M 0.13% 177
2020
Q2
Sell
-2,779
Closed -$207K 298
2020
Q1
$207K Sell
2,779
-2,853
-51% -$197K 0.08% 139
2019
Q4
$365K Sell
5,632
-709
-11% -$46.2K 0.09% 100
2019
Q3
$401K Buy
6,341
+29
+0.5% +$1.9K 0.11% 94
2019
Q2
$426K Buy
6,312
+4,026
+176% +$265K 0.13% 87
2019
Q1
$148K Buy
2,286
+1,165
+104% +$77.4K 0.05% 140
2018
Q4
$70K Sell
1,121
-5,278
-82% -$369K 0.03% 164
2018
Q3
$494K Buy
6,399
+176
+3% +$13.3K 0.15% 79
2018
Q2
$440K Sell
6,223
-21,471
-78% -$1.52M 0.15% 79
2018
Q1
$2.09M Buy
27,694
+24,488
+764% +$1.95M 0.76% 38
2017
Q4
$229K Buy
+3,206
New +$243K 0.08% 105
2017
Q2
Sell
-50
Closed -$3K 465
2017
Q1
$3K Hold
50
﹤0.01% 344
2016
Q4
$3K Buy
+50
New +$3.72K ﹤0.01% 328

Other funds holding GILD

Royal Fund Management's GILD Position: Q2 2026 in Review

Royal Fund Management increased its Gilead Sciences (GILD) stake by 37% in Q2 2026, buying an estimated $91.8K and bringing the position to 2,573 shares worth $325K. The position accounts for 0.03% of the portfolio, ranked #244.

Royal Fund Management first reported a position in GILD in Q4 2016 and has held it in 22 quarters since. The position peaked at $2.09M in Q1 2018. 607 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Royal Fund Management held 2,573 shares of Gilead Sciences worth $325K as of Q2 2026.
  • Royal Fund Management bought 697 Gilead Sciences shares in Q2 2026, an estimated $91.8K.
  • Gilead Sciences made up 0.03% of Royal Fund Management's portfolio in Q2 2026, its #244 holding.
  • Royal Fund Management first reported a position in Gilead Sciences in Q4 2016 and has held it in 22 quarters since.
  • Royal Fund Management's Gilead Sciences position peaked at $2.09M in Q1 2018.
  • 607 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Royal Fund Management's 13F filing for Q2 2026, filed 20 Jul 2026.